6 May 2021
Consilium Strategic Communications Appoints Matthew Cole as Partner
London, 6 May 2021, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is pleased to announce the appointment of Matthew Cole as Partner.
Matthew is a senior communications advisor with more than 15 years’ experience in both in-house and advisory roles within healthcare. He has specialist expertise in financial and corporate communications and investor relations and has been a trusted adviser to Boards and senior management at some of the world’s largest healthcare companies including Smith & Nephew, Hikma, Shire, Novartis, Bupa and UCB.
Most recently, Matthew was Communications Director for Arix Bioscience plc, a London-listed biotech venture capital company. Prior to that, he spent more than a decade at FTI Consulting in London working in a succession of roles within its healthcare & life sciences and investor relations teams.
“I am very pleased to welcome Matthew as a Partner in our firm. He brings a wealth of experience to our team, and further expands our strength and capabilities at a senior level. His appointment reflects Consilium’s continued growth and commitment to delivering the highest quality advice and service for our clients.”
Mary-Jane ElliottManaging Partner of Consilium Strategic Communications
"I am delighted to join Consilium, a clear leader in strategic healthcare communications and investor relations. I look forward to our continued growth as trusted advisors helping established and developing companies achieve their goals to deliver valuable innovation for patients and healthcare providers.”
Matthew ColeMatthew Cole, newly appointed Partner of Consilium Strategic Communications
Matthew Cole can be contacted at Cole@consilium-comms.com
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications and IR programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.